Fig. 7From: Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancerSubgroup analysis of the relationship between advanced lung cancer inflammation index and overall survival (A) and progression-free survival (B) based on the Cox model. HR, hazard ratio; CL, confidence intervalBack to article page